Plain-English translation of NCT01967511 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to understand why some people develop fibromuscular dysplasia, spontaneous coronary artery dissection, or cervical artery dissection—three rare conditions that affect blood vessels. By collecting blood samples, tissue samples, and genetic information from people with these conditions and comparing them to healthy volunteers, scientists hope to discover the genetic and molecular factors that trigger these diseases.
Currently, doctors don't fully understand what causes these three rare artery diseases or why some people are at risk. By studying the genes and molecules in affected patients, researchers hope to identify the biological roots of these conditions, which could eventually lead to better treatments and prevention strategies.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will donate blood and tissue samples that researchers will use to build a library of genetic and molecular information. You may also be asked to provide medical records or answer questions about your health history. The study is recruiting up to 600 people total, and healthy volunteers will be matched to patients based on age and gender.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Enrollment target
~600 participants
Started
October 2013
Primary completion
December 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jason Kovacic, MD, PhD
Icahn School of Medicine at Mount Sinai
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.